Lite Strategy, Inc. (LITS)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Insider purchase
    Flynn James P (director) bought $98k of stock
  4. Material 8-K filing
    Filed 8-K disclosing director or officer change
  5. Material 8-K filing
    Filed 8-K disclosing director or officer change
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-06-24Flynn James PdirectorP25,0000.86$21,500
2025-12-19Flynn James PdirectorP70,0001.4$98,000
2025-12-18Schornstein Alexanderten percent ownerS690,6111.37$946,137
2025-11-19Flynn James PdirectorP12,1001.88$22,748
2025-09-30Flynn James PdirectorA10,0002.54$25,400

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings